Cerebral metastasis during remission after immunotherapy for metastatic urothelial carcinoma: A case report
نویسندگان
چکیده
منابع مشابه
Metastatic skin carcinoma, A Report on a Rare case
SUMMARY Development of metastatic deposits in skin indicates that the cancer is disseminated, and reveals a poor prognosis.but rarely, it is possible for cutaneous metastasis to be the first clinical manifestation of an occult internal malignancy. Unfortunately, a few of cutaneous metastatic deposits have characteristic clinical appearance, that may suggest the possibility of metastasis in dif...
متن کاملCase report: A Metastatic Transitional Cell Carcinoma of the Ovary
Background: Transitional cell carcinoma (TCC) is a rare type of ovarian epithelial cancer. This type of ovarian cancer accounts for only 1% of superficial epithelial carcinomas. Ovarian cancer is a major clinical challenge in obstetrics and gynecology. The reason of this is the lack of specific symptoms for ovarian cancer before the recurrence and progression of the tumor, so many cases are not...
متن کاملNovel immunotherapy approaches for metastatic urothelial and renal cell carcinoma
The treatment of metastatic renal cell carcinoma (RCC) and urothelial carcinoma (UC) remains a major challenge. Past research has implicated the immune system in tumor surveillance of both malignancies, leading to the application of immunotherapy agents for both cancers. Among them, the most promising agents are the checkpoint blockade drugs, such as antibodies targeting the cytotoxic T-lymphoc...
متن کاملSolitary skull metastasis from follicular thyroid carcinoma: a case report
Introduction: Follicular thyroid carcinoma (FTC) is the second most common malignant form of thyroid cancers. FTC is more common in women with a peak incidence in the fifth and sixth decades of life. Invasion into blood vessels may lead to distant metastasis to bone, lung, liver or elsewhere. FTC rarely manifests itself as a distant metastatic lesion, especially as solitary metastasis. Case r...
متن کاملTherapy for Metastatic Urothelial Carcinoma
but little improvement has been achieved in the outcomes of patients with advanced or metastatic disease. Almost 90% of those patients eventually succumb to their cancer. For patients who relapse after first-line chemotherapy, the prognosis is generally poor. To date, there is no real consensus on how to best treat these patients, and most of the available evidence stems from small phase ii tri...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Molecular and Clinical Oncology
سال: 2021
ISSN: 2049-9450,2049-9469
DOI: 10.3892/mco.2021.2307